(The following press release from Eckert & Ziegler was received by e-mail. 
It was not confirmed by the sender.) 
Eckert & Ziegler BEBIG S.A., an associated company of Eckert & Ziegler AG (ISIN 
DE0005659700), announces the signing of a framework agreement for the local 
production of brachytherapy devices with ZAO MSM-Medimpex (hereafter "MSM"), a 
leading Russian distributor of radiation therapy and nuclear medicine 
equipment. The contract covers the sale of production assets from BEBIG to MSM, 
a license for the use of BEBIG know-how, and support for the development of 
local afterloader modules. The agreement will enable MSM to manufacture a line 
of Russian brachytherapy devices for the precise treatment of cancer.  
"The agreement will bring MSM and BEBIG closer together and thereby strengthen 
BEBIG's position in the Russian brachytherapy market", explains Dr. Edgar 
Löffler, Managing Director at Eckert & Ziegler BEBIG. "It allows BEBIG to 
participate more prominently in future Russian government cancer care 
investments, which are expected to increase significantly under the new State 
Oncology Program. Over the last years, BEBIG has already sold over 70 temporary 
brachytherapy systems. There is still an enormous potential for the use of such 
equipment in Russia. Together with MSM we are determined to exploit it. The 
revenues generated by this contract will reach well over 30 million EUR for 
both parties over the following three years." 
"MSM is proud to announce this result of our long-term fruitful collaboration 
with Eckert & Ziegler BEBIG in the field of temporary brachytherapy," says 
Andrey Popov, Director General of MSM. "We have built a strong market presence 
with the BEBIG cancer therapy equipment over the last years due to the unique 
temporary brachytherapy devices with miniaturized Co-60 sources. Also, this 
contract allows us to participate on the Federal Target Program. The local 
production will give us a significant advantage over our competitors in 
upcoming government tenders."  
With more than 600 employees the Eckert & Ziegler Group belongs to the largest 
providers of isotope components for radiotherapy and nuclear medicine worldwide.
Press spacebar to pause and continue. Press esc to stop.